Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

2024 Amsterdam Session on Diabetes Care - Meeting Report

On 9 April 2024, the Access to Medicine Foundation’s Diabetes Care Programme hosted its third ‘Amsterdam Session.’ This session, titled ‘Securing worldwide access to diabetes care by 2030: Spotlight on strategies and solutions to close the equity gap’ focused on how to widen the scope and scale of access to the diabetes continuum of care. Key takeaways from the event have been captured in a meeting report, which is now available for download.

Date

07 May 2024

Download the meeting report

The event was hosted at Deloitte’s offices in Amsterdam and attendees included representatives from leading insulin and glucose self-monitoring device manufacturers, experts from global health organisations, procurement agencies, and government bodies, as well as people living with diabetes (PLWD). Claudia Martínez, the Foundation’s Head of Research, served as the event chair.   

Takeaways from the event 

Practical steps to widen the scope and scale of access to the diabetes continuum of care are captured in the report, alongside good practices and learnings that were identified during the event. The day's discussions elicited three central themes that should be prioritised as companies and other stakeholders in diabetes care design future strategies: 

  1. Centre access efforts around the needs of PLWD 

  1. Create tailored access solutions with sustainability in mind   

  1. Build more efficient and collaborative supply chains  

These three points encompass the ways that companies involved in the diabetes product supply chain can shape their strategies to make a real impact in increasing access to diabetes care in LMICs. Further details of the discussion are shared in the PDF of the meeting report. 

Claudia Martínez

Director of Research

cmartinez@accesstomedicinefoundation.org

Get in touch

Cross-sector programmes

Learn more about our Diabetes Care Programme
News

Drugmakers that dominate the world's insulin market must scale up access efforts globally

06 October 2022
Event

Amsterdam Session on Diabetes Care - Meeting Report

25 July 2023
Media

Project Syndicate op-ed: Insulin Belongs to the World

14 March 2022

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved